Parathyroid Chief Cells, also known as principal cells, are the primary cell type in the parathyroid glands responsible for producing and secreting parathyroid hormone (PTH). These small endocrine glands, typically four in number, are located adjacent to the thyroid gland in the neck. Parathyroid hormone plays a central role in calcium homeostasis and bone metabolism. Chief cells in the parathyroid glands are sensitive to changes in blood calcium levels. When blood calcium concentrations decrease, chief cells respond by releasing PTH. Parathyroid hormone acts on the bones, kidneys, and intestines to elevate blood calcium levels. In bones, PTH stimulates the release of calcium and phosphate, while in the kidneys, it promotes calcium reabsorption and phosphate excretion. Additionally, PTH stimulates the production of active vitamin D in the kidneys, enhancing calcium absorption in the intestines. The regulation of parathyroid chief cells is finely tuned by a negative feedback loop. As blood calcium levels increase, PTH secretion decreases, preventing hypercalcemia. Conversely, when blood calcium levels decrease, PTH release is stimulated, preventing hypocalcemia. Dysfunction of parathyroid chief cells can lead to disorders such as primary hyperparathyroidism, characterized by excessive PTH secretion. This condition results in elevated blood calcium levels, contributing to symptoms like kidney stones, bone pain, and fatigue. Parathyroid chief cells are identified histologically through immunohistochemical staining techniques that target PTH. The discovery of these cells and their role in calcium regulation has profound implications for understanding bone metabolism and disorders related to calcium imbalance. In summary, parathyroid chief cells are central players in calcium homeostasis, releasing parathyroid hormone to regulate calcium levels in the blood and tissues. Their function is crucial for maintaining physiological balance and preventing abnormalities associated with calcium dysregulation.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy